Redak slučaj metastatskog spermatocitnog tumora kod psa bez sarkomatoznih i anaplastičnih promena by Lee, Eun-Joo et al.
239




*Corresponding author: e-mail: jeongks@knu.ac.kr
A RARE CASE OF CANINE METASTATIC SPERMATOCYTIC 
TUMOR WITHOUT SARCOMATOUS AND ANAPLASTIC 
VARIANTS
Eun-Joo LEE1, Jae-Hyuk YIM1, Myung-Jin CHUNG1, Jin-Kyu PARK1, 
Il-Hwa HONG2, Kyu-Shik JEONG1,*
 1College of  Veterinary Medicine, Department of  Veterinary pathology Kyungpook National University, 
Daegu City, Republic of  Korea; 2College of  Veterinary Medicine, Department of  Veterinary pathology 
Gyeongsang National University, Chinju City, Republic of  Korea
(Received 18 April, Accepted 04 June 2021)
Spermatocytic tumor is a rare testicular tumor, which is originated from gonocytes. 
It is characterized by the histological feature of  tripartite which is composed of  
large, medium, and lymphocyte-like small cells. It is well-known that spematocytic 
tumor is benign, thus a good prognosis is expected after simple resection. Metastatic 
spermatocytic tumor is extremely rare and usually accompanied by histological variants 
including sarcomatous changes and anaplastic variants. In this case, however, we report 
a canine metastatic spermatocytic tumor without prominent sarcomatous changes 
and anaplastic variants. The mass was composed of  three kinds of  cells including 
large, medium, and small cells with high pleomorphism. The neoplastic cells had 
an indistinct cytoplasmic border and mitotic fi gures were frequently observed. The 
primary spermatocytic tumor metastasized to the abdominal organs one month after 
the resection, and the dog died 13 months after the surgery. Thus, careful follow-up 
is recommended after surgical resection of  canine spermatocytic tumor even though 
metastasis in spermatocytic tumors is rare. 
Key words: Canine testicular tumor, Canine spermatocytic tumor, Metastasis, 
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INTRODUCTION
The testicular tumor is the second most frequently reported tumor in male dogs, 
which accounts for 7 ~ 16 % of  tumors in intact male dogs [1]. The most common 
testicular tumors in dogs are seminoma, Sertoli cell tumor, and Leydig cell tumor 
with similar incidence. Seminoma is classifi ed into two subtypes; one is classical 
seminoma and the other is spermatocytic tumor depending on the histopathological 
and immunohistochemical characteristics, malignancy, and incidence [2]. The classical 
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seminoma represents malignancy with high incidence rate, whereas spermatocytic 
tumor is benign and non-aggressive, which hardly metastasizes to other organs. 
Although rare, there are few cases of  metastatic spermatocytic tumors in humans 
that metastasize to the liver, lung, lymph nodes, and brain [3-6]. Most of  metastatic 
spermatocytic tumors accompany histological variants including sarcomatous 
transformation and anaplastic variants. It is previously reported that the origin of  the 
metastasized tumor is a sarcomatous component in human spermatocytic tumors [3]. 
Thus, it has been suggested that sarcomatous transformation is one of  the predictors 
of  metastasis in spermatocytic tumors [7]. Here, however, we report a canine metastatic 
spermatocytic tumor, which is an extremely rare case even without any sarcomatous 
and anaplastic changes. 
CASE PRESENTATION
An eight-year-old male Maltese was admitted to the animal hospital with abdominal 
distention. He had cryptorchidism. There were no signifi cant clinical symptoms 
including anorexia and inactivity. On X-ray examination, a globule-shaped opaque 
mass was observed in the left abdomen (Figure 1A). The size of  the mass rapidly 
increased upon the X-ray examination and the mass was surgically removed. The mass 
was well-circumscribed from the adjacent tissue and encapsulated with fi brous tissue. 
The mass was slightly fi rm with a gelatinous texture. The mass was globule-shaped 
and grayish-white and reddish in color. The size of  the mass was 8 8 10 cm3, which 
was remarkably large when considering that the body weight of  the dog was 3.32 kg 
(Figure 1B). The cut surface revealed a solid form with hemorrhage and mild edema. 
One month after the tumor resection, he presented symptoms of  vomiting, diarrhea, 
and cough. Metastases to the abdominal organs including liver, spleen, and urinary 
bladder were observed on sonography and ascites was remarkable. He died 13 months 
after the tumor resection. For histopathological analysis, the mass was fi xed in 10% 
neutral formalin. The fi xed tissue was routinely processed, embedded in paraffi n, 
and cut into 6 µm thickness. Hematoxylin-eosin (H&E) staining was performed. For 
immunohistochemistry, the antigens were retrieved using heated-sodium citrate buffer. 
After antigen retrieval, blocking, primary antibody reaction, and secondary antibody 
reaction were sequentially performed at room temperature for 1 hour each using 
Vectastatin Elite ABC kit. The primary antibodies used in this study were as follows: 
anti-vimentin, anti-CD30, anti-OCT3/4, and anti-CK8/18 antibody (Santa cruz). 
On microscopic fi ndings, the mass had a tripartite cell population which is composed 
of  large, medium, and small lymphocyte-like cells, which is one of  the main features 
of  spermatocytic tumor that distinguishes it from other testicular tumors. The 
neoplastic cells had large and oval shaped nuclei and scant cytoplasm. The nuclei of  the 
neoplastic cells were vesicular and overlapped, representing moderate anisokaryosis. 
Also, the neoplastic cells had densely packed crowded nuclei. Mitotic fi gures were 
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frequently observed. Importantly, it was hard to fi nd sarcomatous changes that are 
usually accompanied by metastatic spermatocytic tumor. 
It is important to make a differential diagnosis in testicular tumors, since testicular tumors 
share similar histological features, especially when representing high pleomorphism and 
malignancy. Mainly, the spermatocytic tumor needs to be differentiated from classical 
seminoma, embryonal carcinoma, and testicular lymphoma. The classical seminoma 
presents a fi brovascular septum with remarkable infi ltration of  lymphocytes and the 
neoplastic cells of  classical seminoma have a distinct cytoplasmic border. However, this 
case did not have a fi brovascular septum and remarkable lymphocyte infi ltration, as 
well as the neoplastic cells had indistinct cytoplasmic borders, which leads to making a 
diagnosis as spermatocytic tumor, not classical seminoma. Unlike testicular lymphoma 
which has pale and abundant cytoplasm with a well-defi ned cytoplasmic membrane, 
this case represents amphophilic cytoplasm with indistinct cytoplasmic borders, except 
for a few clear cell-like cells. Due to the indistinct cytoplasmic membrane and aggressive 
features including metastasis and crowded nuclei, embryonal carcinoma was regarded 
as one of  the possible diagnoses. However, the possibility of  embryonal carcinoma 
could be excluded since this case did not represent epithelial differentiation which is 
one of  the critical histological characteristics of  embryonal carcinoma (Figure 2).  
Figure 1. (A) X-ray imaging. A globule-shaped opaque region in the abdominal cavity. Arrows 
indicate the margin of  the mass. (B) Gross observation. The mass was encapsulated with 
collagen fi ber and well-circumscribed from the adjacent tissue. 
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CD30 - - - +
Oct3/4 - - + +
Vimentin - - - -
CK8/18 - - - +
The immunohistochemistry is also helpful for the differential diagnosis of  
spermatocytic tumor from other testicular tumors, especially when the tumor does 
not represent typical histological features due to poor differentiation and high 
pleomorphism. It is known that spermatocytic tumors are negative for the staining 
of  OCT3/4, CD30, placental alkaline phosphatase (PLAP), vimentin, and AE1/AE3, 
whereas classical seminoma and embryonal carcinoma are positive for PLAP and 
OCT3/4 [8]. This case was negative for CD30, OCT3/4, and vimentin (Figure 4). 
CD30 is a valuable marker to distinguish seminoma from embryonal carcinoma since 
seminoma is negative for CD30 whereas embryonal carcinoma is positive for CD30 
[9]. The positivity for OCT3/4 is well-known as a critical marker of  classical seminoma 
and embryonal cell carcinoma, whereas spermatocytic tumor is negative for OCT3/4 
[10]. Thus, the negativity for OCT3/4 in the present case may exclude the possibility 
of  classical seminoma and embryonal carcinoma though there is a report that canine 
classical seminoma presents little immunoreactivity to OCT3/4 unlike human classical 
seminoma [9]. Vimentin is a well-known mesenchymal cell marker and the negativity 
for vimentin helps to exclude Sertoli cell tumor in the differential diagnosis. Thus, 
this case was diagnosed as a spermatocytic tumor based on the histopathological and 
immunohistochemical characteristics (Figure 3).
Figure 2. Microscopic observation. (A) and (B) The mass was solid and sheet form. Tripartite 
cellular population was observed including large (white arrows), intermediate (black arrows), 
and small (arrow head) size cells. Mitotic fi gures were frequently observed (thin arrows). The 
neoplastic cells had large and oval nuclei and scant cytoplasm. Mitotic fi gures were frequently 
observed. Scale bar = 50 µm. 
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The canine seminoma used to be classifi ed into three subtypes; intratubular type 
without invasion, intratubular type with invasion, and diffuse type [11]. Recently, 
however, a growing body of  cases has been reported that the canine seminoma can 
be classifi ed into two subtypes like human and each canine subtype resembles human 
counterparts. Grieco et al. revealed that canine seminomas are classifi ed into classical 
seminoma and spermatocytic tumor based on the their distinct histochemical and 
immunohistochemical features. The canine classical seminoma is positive for placental 
alkaline phosphatase (PLAP) and periodic acid-Schiff  (PAS) staining, whereas the 
canine spermatocytic tumor is negative for both stainings. [12]. Also, canine seminoma 
is divided into two groups in terms of  angiogenesis evaluated by microvessel density 
and vascular parameters. It was reported that canine classical seminoma presented 
signifi cantly higher microvessel density and increased vascular parameters than 
spermatocytic tumor [13]. 
It has been suggested that the size of  human spermatocytic tumor is correlated to the 
incidence of  metastasis. It is reported that the average size of  metastatic spermatocytic 
tumor was 92.5 mm, while 67.5 mm in non-metastatic spermatocytic tumor, indicating 
that the metastatic spermatocytic tumor is statistically signifi cantly larger than the non-
metastatic one [7]. Considering that it was a small dog weighing 3.32 kg, the size 
Figure 3. Immunohistochemical fi ndings. The mass was negative for (A) CD30, (B) OCT3/4, 
(C) vimentin, (D) CK8/18. Scale bar = 200 µm.
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of  the tumor was remarkably large (8 8 10 cm3) in this case. The metastasis in this 
case may have a correlation to the size of  the mass. The larger tumors have more 
chances to be physically adjacent to large blood vessels, which increase the possibility 
of  neoplastic cells to enter the blood stream. Also, the hypoxia condition caused by the 
rapid proliferation of  neoplastic cells of  large tumors stimulates neovascularization 
[14]. Neovascularization is required to supply nutrients and oxygen to actively 
dividing neoplastic cells and remove waste. The immature blood vessels formed by 
neovascularization show high permeability, thus enhance tumor cells to enter the 
bloodstream [15]. Therefore, the large tumor, especially presenting rapid growth, may 
be one of  the predictors for metastasis even though spermatocytic tumor is typically 
non-metastatic. 
Cryptorchidism is one of  the risk factors of  testicular tumors, especially Sertoli cell 
tumors and seminomas in both humans and dogs [16, 17]. It is reported that testes with 
cryptorchidism have a 13.6 times higher incidence of  testicular tumor than normal 
scrotal testes which were evaluated in 410 cases [17]. It has been reported in patients 
who underwent orchiopexy that the longer the exposure time to cryptorchidism is, 
the higher the incidence of  testicular tumor is [18]. Also, the testicular tumor tends 
to show higher malignancy when accompanying cryptorchidism [19]. From the 
authors’ knowledge, however, there is a paucity of  studies on the correlation between 
cryptorchidism and metastasis of  spermatocytic tumor, which may be due to the 
extremely low incidence of  metastatic spermatocytic tumor in dogs. In spermatocytic 
tumors, cryptorchidism may affect incidence, malignancy, and metastasis of  
spermatocytic tumors as in other testicular tumors, by providing an optimal tumor 
microenvironment such as higher temperature than scrotal testes. 
In this study, we reported canine metastatic spermatocytic tumor, which is an 
extremely rare case. It suggests that the possibility of  metastasis of  spermatocytic 
tumor without sarcomatous and anaplastic changes. When considering the low 
incidence of  spermatocytic tumors, the metastasis without histological variants in 
spermatocytic tumors provides valuable information for further treatment strategy. 
It is recommended to continue follow-up after orchiectomy or surgical removal of  
spermatocytic tumor, considering the possibility of  metastasis as shown in this case, 
although very rare. 
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REDAK SLUČAJ METASTATSKOG SPERMATOCITNOG 
TUMORA KOD PSA BEZ SARKOMATOZNIH I
ANAPLASTIČNIH PROMENA
Eun-Joo LEE, Jae-Hyuk YIM, Myung-Jin CHUNG, Jin-Kyu PARK, 
Il-Hwa HONG, Kyu-Shik JEONG
Spermatocitni tumor je redak tumor testisa, koji potiče od gonocita. Karakteriše ga 
histološki nalaz tri morfološka tipa ćelija, a sastoji se od velikih, srednjih i limfocitima 
sličnih malih ć elija. Dobro je poznato da je spermatocitni tumor benignog ponašanja 
pa se očekuje dobra prognoza nakon jednostavne resekcije. Metastatski spermatocitni 
tumor izuzetno je redak i obično je prać en histološkim varijacijama, uključujuć i sar-
komatozne i anaplastične promene. U ovom slučaju, međutim, opisan je metastatski 
spermatocitni tumor bez izraženih sarkomatoznih promena i anaplastičnih varijanti. 
Masa se sastojala od tri vrste ć elija, uključujuć i velike, srednje i male ć elije sa visokim 
pleomorfi zmom. Neoplastične ć elije su imale nejasnu citoplazmatsku granicu i često 
su primeć ene mitotičke fi gure. Primarni spermatocitni tumor metastazirao je na trbuš-
ne organe mesec dana nakon resekcije, a pas je uginuo 13 meseci nakon operacije. Sto-
ga se preporučuje pažljivo prać enje nakon hirurške resekcije spermatocitnog tumora 
mada su metastaze u spermatocitnim tumorima retke.
